You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › July › 29
CagriSema
14 hours ago
Investors claim Novo Nordisk misled the market about CagriSema's tolerability, after disappointing clinical trial results wiped billions off its market cap.
page 1 of 1